Aftab Dana
Officer at EXEL
- Sold, on record
- $16.7M
- Dollars the filings state
- Form 4 sales
- 12
- Latest May 26, 2026
- Form 144 notices
- 11
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- EXELEXELIXIS, INC.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice EXELNoticeNov 11, 2025 2025
Filed to sell 48,383 shares ($2.1M)
Aftab Dana, Officer
No 10b5-1 plan2x usual sizeFiling
- 2 Form 4 sale EXELNo planNov 11, 2025 same day
Sold 48,383 shares at $42.50 ($2.1M)
Aftab Dana, EVP, Research and Development
No 10b5-1 planSold 6.8% of holdings ($30.3M position)664,778 shares left2x usual sizeFollows a Form 144Filing
- 3 Form 144 notice EXELNoticeFeb 19, 2026 +100 days
Filed to sell 29,873 shares ($1.3M)
Aftab Dana, Officer
No 10b5-1 plan1.1x usual sizeFiling
- 4 Form 4 sale EXELNo planFeb 19, 2026 same day
Sold 29,873 shares at $44.35 ($1.3M)
Aftab Dana, EVP, Research and Development
No 10b5-1 planSold 4.3% of holdings ($30.8M position)664,024 shares left1.1x usual sizeFollows a Form 144Filing
- 5 Form 144 notice EXELNoticeFeb 24, 2026 +5 days
Filed to sell 47,918 shares ($2.1M)
Aftab Dana, Officer
No 10b5-1 plan1.7x usual sizeFiling
- 6 Form 4 sale EXELNo planFeb 24, 2026 same day
Sold 47,918 shares at $44.50 ($2.1M)
Aftab Dana, EVP, Research and Development
No 10b5-1 planSold 7.2% of holdings ($29.5M position)616,106 shares left1.7x usual sizeFollows a Form 144Filing
- 7 Form 144 notice EXELNoticeMay 26, 2026 +91 days
Filed to sell 43,451 shares ($2.2M)
Aftab Dana, Officer
No 10b5-1 plan1.5x usual sizeFiling
- 8 Form 4 sale EXELNo planMay 26, 2026 same day
Sold 43,451 shares at $50.35 ($2.2M)
Aftab Dana, EVP, Research and Development
No 10b5-1 planSold 6.8% of holdings ($32.1M position)594,741 shares left1.5x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (23)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 26, 2026 | May 28, 2026 | EXEL | EVP, Research and Development | Form 4 sale | 43,451 | $2.2M | 6.8% | No plan | SEC |
| May 26, 2026 | May 26, 2026 | EXEL | Officer | Form 144 notice | 43,451 | $2.2M | Notice | SEC | |
| Feb 24, 2026 | Feb 26, 2026 | EXEL | EVP, Research and Development | Form 4 sale | 47,918 | $2.1M | 7.2% | No plan | SEC |
| Feb 24, 2026 | Feb 24, 2026 | EXEL | Officer | Form 144 notice | 47,918 | $2.1M | Notice | SEC | |
| Feb 19, 2026 | Feb 23, 2026 | EXEL | EVP, Research and Development | Form 4 sale | 29,873 | $1.3M | 4.3% | No plan | SEC |
| Feb 19, 2026 | Feb 19, 2026 | EXEL | Officer | Form 144 notice | 29,873 | $1.3M | Notice | SEC | |
| Nov 11, 2025 | Nov 13, 2025 | EXEL | EVP, Research and Development | Form 4 sale | 48,383 | $2.1M | 6.8% | No plan | SEC |
| Nov 11, 2025 | Nov 12, 2025 | EXEL | Officer | Form 144 notice | 48,383 | $2.1M | Notice | SEC | |
| May 1, 2025 | May 5, 2025 | EXEL | CSO/EVP Disc & Trans Research | Form 4 sale | 1,508 | $59k | 0.2% | Routine | SEC |
| May 1, 2025 | May 1, 2025 | EXEL | Officer | Form 144 notice | 1,508 | $59k | Notice | SEC | |
| Feb 24, 2025 | Feb 26, 2025 | EXEL | CSO/EVP Disc & Trans Research | Form 4 sale | 26,987 | $992k | 5.0% | No plan | SEC |
| Feb 24, 2025 | Feb 24, 2025 | EXEL | Officer | Form 144 notice | 26,987 | $992k | Notice | SEC | |
| Nov 5, 2024 | Nov 7, 2024 | EXEL | CSO/EVP Disc & Trans Research | Form 4 sale | 96,986 | $3.4M | 16.3% | Unusual | SEC |
| Nov 5, 2024 | Nov 5, 2024 | EXEL | Officer | Form 144 notice | 96,986 | $3.4M | Notice | SEC | |
| Oct 30, 2024 | Nov 1, 2024 | EXEL | CSO/EVP Disc & Trans Research | Form 4 sale | 1,162 | $36k | 0.2% | Routine | SEC |
| Oct 30, 2024 | Oct 30, 2024 | EXEL | Officer | Form 144 notice | 1,162 | $36k | Notice | SEC | |
| Aug 12, 2024 | Aug 14, 2024 | EXEL | CSO/EVP Disc & Trans Research | Form 4 sale | 20,883 | $565k | 4.0% | No plan | SEC |
| Aug 9, 2024 | Aug 9, 2024 | EXEL | Officer | Form 144 notice | 20,883 | $569k | Notice | SEC | |
| Aug 7, 2024 | Aug 9, 2024 | EXEL | CSO/EVP Disc & Trans Research | Form 4 sale | 95,000 | $2.4M | 15.4% | Routine | SEC |
| Aug 7, 2024 | Aug 7, 2024 | EXEL | Officer | Form 144 notice | 95,000 | $2.4M | Notice | SEC | |
| Aug 30, 2023 | Sep 1, 2023 | EXEL | CSO/EVP Disc & Trans Research | Form 4 sale | 4,600 | $103k | 1.1% | Routine | SEC |
| Aug 30, 2023 | Aug 30, 2023 | EXEL | Officer | Form 144 notice | 4,600 | $103k | Notice | SEC | |
| Feb 28, 2023 | Mar 1, 2023 | EXEL | CSO/EVP Disc & Trans Research | Form 4 sale | 82,500 | $1.4M | 19.0% | Plan not stated | SEC |